Physiology and pathophysiology of poly(ADP-ribosyl)ation

BioEssays

Volumn 23, Issue 9, 2001, Pages 795-806

  Bürkle, Alexander ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE PROTEINASE; MULTIENZYME COMPLEX; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; POLY(ADENOSINE DIPHOSPHATE RIBOSE); PROTEASOME;

ANIMAL; BIOLOGICAL MODEL; DNA DAMAGE; DNA REPAIR; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; INFARCTION; INSULIN DEPENDENT DIABETES MELLITUS; METABOLISM; PATHOPHYSIOLOGY; REVIEW;

ANIMALS; CYSTEINE ENDOPEPTIDASES; DIABETES MELLITUS, TYPE 1; DNA DAMAGE; DNA REPAIR; GENE EXPRESSION REGULATION; HUMANS; INFARCTION; MODELS, BIOLOGICAL; MULTIENZYME COMPLEXES; POLY ADENOSINE DIPHOSPHATE RIBOSE; POLY(ADP-RIBOSE) POLYMERASES; PROTEASOME ENDOPEPTIDASE COMPLEX; TRANSCRIPTION, GENETIC;

EID: 0034814670     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/bies.1115     Document Type: Review

References (70)

1. Nicotinamide mononucleotide activation of a new DNA-dependent polyadenylic acid synthesizing nuclear enzyme
2. Discovering new ADP-ribose polymer cycles: Protecting the genome and more
3. Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions
4. Poly(ADP-ribose) polymerase-1: What have we learned from the deficient mouse model?
5. Roles of poly(ADP-ribosyl)ation and PARP in apoptosis, DNA repair, genomic stability and functions of p53 and E2F-1
6. Poly(ADP-ribose) polymerase-1 in the nervous system
7. Defending genome integrity over life span: A proposed role for PARP-1
8. Poly(ADP-ribosyl)ation, a DNA damage-driven protein modification and regulator of genomic instability
9. The world according to PARP
10. Poly(ADP-ribose) polymerase null mouse cells synthesize ADP-ribose polymers
11. Characterization of sPARP-1. An alternative product of PARP-1 gene with poly(ADP-ribose) polymerase activity independent of DNA strand breaks
12. Structure of the catalytic fragment of poly(AD-ribose) polymerase from chicken
13. Poly(ADP-ribose) polymerase is a catalytic dimer and the automodification reaction is intermolecular
14. Regulation of the human poly(ADP-ribose) polymerase promoter by the ETS transcription factor
15. New polymorphisms in the human poly(ADP-ribose) polymerase-1 coding sequence: Lack of association with longevity or with increased cellular poly(ADP-ribosyl)ation capacity
16. Dinucleotide repeat polymorphism at the human poly (ADP-ribose) polymerase gene (PPOL)
17. Mammalian meiotic telomeres: Protein composition and redistribution in relation to nuclear pores Mol Biol Cell
18. Tankyrase promotes telomere elongation in human cells
19. Tankyrase is a golgi-associated mitogen-activated protein kinase substrate that interacts with IRAP in GLUT4 vesicles
20. Poly(ADP-ribose) polymerase activity in mononuclear leukocytes of 13 mammalian species correlates with species-specific life span
21. Poly(ADP-ribose) binds to specific domains in DNA damage checkpoint proteins
22. The response of Parp knockout mice against DNA damaging agents
23. Increased susceptibility of poly(ADP-ribose) polymerase-1 knockout mice to nitrosamine carcinogenicity
24. DNA excision repair and DNA damage-induced apoptosis are linked to Poly(ADP-ribosyl)ation but have different requirements for p53
25. Inhibition of poly(ADP-ribose) polymerase activity is insufficient to induce tetraploidy
26. Negative regulation of alkylation-induced sister-chromatid exchange by poly(ADP-ribose) polymerase-1 activity
27. Histone carbonylation in vivo and in vitro
28. Misregulation of gene expression in primary fibroblasts lacking poly(ADP-ribose) polymerase
29. Mitotic misregulation and human aging
30. Evidence for regulation of NF-kB by poly(ADP-ribose) polymerase
31. A role for poly ADP-ribose polymerase (PARP) in the transcriptional regulation of melanoma growth stimulatory activity (CXCL1) gene expression
32. Functional interaction of poly(ADP-ribose) with the 20S proteasome in vitro
33. Poly-ADP ribose polymerase activates nuclear proteasome to degrade oxidatively damaged histones
34. Proteasome activation by poly-ADP-ribose-polymerase in human myelomonocytic cells after oxidative stress
35. Functions of poly(ADP-ribose) polymerase in controlling telomere length and chromosomal stability
36. Comparative characterisation of poly(ADP-ribose) polymerase-1 from two mammalian species with different life span
37. Age-related alteration of poly(ADP-ribose) polymerase activity in different parts of the brain
38. Activation of Reg gene, a gene for insulin-producing beta-cell regeneration: Poly(ADP-ribose) polymerase binds Reg promoter and regulates the transcription by autopoly(ADP-ribosyl)ation
39. Diabetic endothelial dysfunction: The role of poly(ADP-ribose) polymerase activation
40. Activation of poly(ADP-ribose) polymerase in the rat hippocampus may contribute to cellular recovery following sublethal transient global ischemia
41. Effects of transient global ischaemia and kainate on poly(ADP-ribose) polymerase (PARP) gene expression and proteolytic cleavage in gerbil and rat brains
42. Effects of 5-aminoisoquinolinone, a watersoluble, potent inhibitor of the activity of poly (ADP-ribose) polymerase on the organ injury and dysfunction caused by haemorrhagic shock
43. 2 and PARS mediate lung P-selectin upregulation in acute pancreatitis
44. Role of poly-(ADP-ribose) synthetase in lipopolysaccharide-induced vascular failure and acute lung injury in pigs
45. inhibition of poly(ADP-ribose) polymerase attenuates inflammation in a model of chronic colitis
46. PARP degradation in apoptotic Syrian hamster embryo (SHE) cells compared to HL60 celt line
47. Inhibition of homodimerization of poly(ADP-ribose) polymerase by its C-terminal cleavage products produced during apoptosis
48. 2+-dependent endonuclease in apoptosis and its inhibition by Poly(ADP-ribose) polymerase
49. Inhibition of caspase-3-mediated poly(ADP-ribose) polymerase (PARP) apoptotic cleavage by human PARP autoantibodies and effect on cells undergoing apoptosis
50. Caspase-3-mediated processing of poly(ADP-ribose) glycohydrolase during apoptosis
51. Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitro
52. All trans retinoic acid induces apoptosis in acute promyelocytic NB4 cells when combined with isoquinolinediol, a poly(ADP-ribose) polymerase inhibitor
53. Potentiation of temozolomide and topotecan growth inhibition and cytotoxicity by novel poly(adenosine diphosphoribose) polymerase inhibitors in a panel of human tumor cell lines
54. Resistance-modifying agents. 9.(1) Synthesis and biological properties of benzimidazole inhibitors of the DNA repair enzyme poly(ADP-ribose) polymerase
55. 2 cytotoxicity by inhibiting poly(ADP-ribose) polymerase
56. Poly(ADP-ribose) polymerase is a B-MYB coactivator
57. identification of Poly(ADP-ribose) polymerase as a transcriptional coactivator of the human T-cell leukemia virus type 1 tax protein
58. Increased resistance to anticancer therapy of mouse cells lacking the poly(ADP-ribose) polymerase attributable to up-regulation of the multidrug resistance gene product P-glycoprotein
59. A cellular defense pathway regulating transcription through poly(ADP-ribosyl)ation in response to DNA damage
60. Poly(ADP-ribose) synthase inhibition reduces ischemic injury and inflammation in neonatal rat brain
61. The neuroprotective effect of cerebral poly(ADP-ribose)polymerase inhibition in a rat model of global ischemia
62. NMDA but not non-NMDA excitotoxicity is mediated by Poly(ADP-ribose) polymerase
63. Post-treatment at 12 or 18 hours with 3-aminobenzamide ameliorates retinal ischemia-reperfusion damage
64. Apoptosis in the dorsal lateral geniculate nucleus after monocular deprivation involves glutamate signaling, NO production, and PARP activation
65. Myocardial postischemic injury is reduced by polyADPripose polymerase-1 gene disruption
66. Inhibitors of poly (ADP-ribose) synthetase reduce renal ischemia-reperfusion injury in the anesthetized rat in vivo
67. Inhibition of poly(ADP-ribose) polymerase attenuates ischemic renal injury in rats
68. ATP for the DNA ligation step in base excision repair is generated from poly(ADP-ribose)
69. Poly (ADP-ribose) synthetase mediates intestinal mucosal barrier dysfunction after mesenteric ischemia